Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dynorphin-independent spinal cannabinoid antinociception.

L R Gardell1, M H Ossipov, T W Vanderah

  • 1Department of Pharmacology, College of Medicine, University of Arizona Health Sciences Center, 85724 Tucson, AZ, USA Department of Anesthesiology, College of Medicine, University of Arizona Health Sciences Center, Tucson, AZ, USA.

Pain
|December 7, 2002
PubMed
Summary

Spinal cannabinoid agonists, like delta 9-tetrahydro-cannabinol (Delta(9)-THC), reduce pain directly via cannabinoid receptors. This occurs without needing dynorphin release or kappa opioid receptor activation, as shown in prodynorphin knockout mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between poor glycemic control and apical periodontitis: A systematic review and meta-analysis.

Medicina oral, patologia oral y cirugia bucal·2026
Same author

Piezo Channels in Dentistry: Decoding the Functional Effects of Forces.

Journal of dental research·2025
Same author

Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M).

Contemporary clinical trials communications·2025
Same author

Ethyl methanesulfonate (EMS) mediated dwarfing mutation provides a basis for CaCO<sub>3</sub> accumulation by enhancing photosynthetic performance in Ceratostigma willmottianum Stapf.

Plant biology (Stuttgart, Germany)·2024
Same author

PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination.

Journal of endocrinological investigation·2024
Same author

[Single-cell transcriptomic sequencing coupled with Mendelian randomization analysis elucidates the pivotal role of <i>CTSC</i> in chronic rhinosinusitis].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2024

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Spinal antinociception from cannabinoid agonists is hypothesized to involve dynorphin release acting on kappa opioid receptors.
  • Alternatively, cannabinoids may act directly on spinal cannabinoid receptors to inhibit pain signaling.

Purpose of the Study:

  • To investigate the mechanism of spinal antinociception induced by cannabinoid agonists.
  • To determine if dynorphin release and kappa opioid receptor activation are required for cannabinoid-mediated pain relief.

Main Methods:

  • Used prodynorphin knockout mice and wild-type littermates to assess antinociceptive effects of spinal delta 9-tetrahydro-cannabinol (Delta(9)-THC) and WIN 55,212-2.
  • Administered kappa opioid receptor antagonist (nor-binaltorphimine) and cannabinoid receptor antagonist (SR141716A) to evaluate receptor involvement.

Related Experiment Videos

  • Constructed antinociceptive dose-response curves.
  • Main Results:

    • Delta(9)-THC and WIN 55,212-2 were equally effective in both prodynorphin knockout and wild-type mice.
    • Kappa opioid receptor antagonist (nor-BNI) did not affect cannabinoid-induced antinociception but blocked U50,488H-induced effects.
    • Cannabinoid receptor antagonist (SR141716A) blocked the antinociceptive actions of both Delta(9)-THC and WIN 55,212-2.

    Conclusions:

    • Spinal cannabinoid-mediated antinociception likely occurs through direct activation of cannabinoid receptors.
    • Dynorphin release and subsequent kappa opioid receptor activation are not required for this antinociceptive effect.